Biatrial Versus Left Atrial Maze Ablation During Cardiac Valve Surgery for Persistent Atrial Fibrillation: The ABLATION Trial

BACKGROUND: Guidelines recommend concomitant surgical ablation during cardiac surgery in patients with atrial fibrillation (AF). However, the optimal lesion set remains uncertain, with ongoing debate regarding the relative benefits and risks of biatrial versus left atrial (LA) maze ablation. METHODS: In this multicenter, randomized, single-blind trial, patients with persistent or long-standing persistent AF undergoing rheumatic mitral valve surgery, with or without concomitant cardiac surgical procedures, were randomly assigned in a 1:1 ratio to undergo biatrial or LA maze ablation. The biatrial group underwent a complete Cox-Maze IV procedure; the LA group received a left-sided maze lesion set. To ensure standardization and consistency of the ablation procedures, surgeons underwent pretrial training and certification, and all procedures were videorecorded and centrally reviewed. The primary outcome was freedom from atrial tachyarrhythmias lasting >30 seconds without antiarrhythmic drugs within 12 months. The key secondary end point was freedom from permanent pacemaker implantation. RESULTS: All 323 randomized patients were included in the intention-to-treat analysis (mean age, 56.5 years; 72.1% women; mean LA diameter, 51.9 mm). At 12 months, 78.7% of patients (129 of 164) in the biatrial group and 68.6% (109 of 159) in the LA group were free from atrial tachyarrhythmias (adjusted difference, 10.7% [1-sided lower 95% CI, 3%]; P =0.01). Freedom from permanent pacemaker implantation was noted in 97.0% (159 of 164) of the biatrial group and 98.1% (156 of 159) of the LA group, meeting the predefined noninferiority criterion with a margin of −5% (adjusted difference, –1.1% [1-sided lower 95% CI, –3.9%]; P noninferiority =0.01). CONCLUSIONS: Among patients with persistent or long-standing persistent AF undergoing rheumatic cardiac valve surgery, biatrial maze ablation was superior to LA maze ablation in reducing recurrent atrial tachyarrhythmias, while maintaining noninferiority with respect to permanent pacemaker implantation. These findings provide direct evidence to inform lesion-set selection for surgical ablation during cardiac surgery. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05021601.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2026-11-16
DOI
https://doi.org/10.1161/circulationaha.126.083005
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Biatrial Versus Left Atrial Maze Ablation During Cardiac Valve Surgery for Persistent Atrial Fibrillation: The ABLATION Trial

Jianglong Hou, Chunyu Yu, Shuiyun Wang, 程兆云 et al.
1 links
Circulation
Atrial Fibrillation Management and Outcomes
article

Biatrial Versus Left Atrial Maze Ablation During Cardiac Valve Surgery for Persistent Atrial Fibrillation: The ABLATION Trial

Jianglong Hou, Chunyu Yu, Shuiyun Wang, 程兆云, Yan Zhao, Zhi Yi Fang, Zhe Zheng, 熊辉, 王小启, Jinping Liu, Xin Yuan, H M Guo, Sheng Liu, Heng Zhang, Li Haojie, Liang Ma, Yongfeng Shao, Yang Yan, Tian Hai, Zhongchen Li, Yang Wang, Ye Kong, Zhi Lin, Fei Xu, Yukui Du, Xiaopeng Hu, Fei Li, Ying Zhang, Liming Liu, Jue Wang, Ziniu Zhao, Xin Chen, Jun Pan, Zhigang Liu, Qing Zhou
article en

Abstract

BACKGROUND: Guidelines recommend concomitant surgical ablation during cardiac surgery in patients with atrial fibrillation (AF). However, the optimal lesion set remains uncertain, with ongoing debate regarding the relative benefits and risks of biatrial versus left atrial (LA) maze ablation. METHODS: In this multicenter, randomized, single-blind trial, patients with persistent or long-standing persistent AF undergoing rheumatic mitral valve surgery, with or without concomitant cardiac surgical procedures, were randomly assigned in a 1:1 ratio to undergo biatrial or LA maze ablation. The biatrial group underwent a complete Cox-Maze IV procedure; the LA group received a left-sided maze lesion set. To ensure standardization and consistency of the ablation procedures, surgeons underwent pretrial training and certification, and all procedures were videorecorded and centrally reviewed. The primary outcome was freedom from atrial tachyarrhythmias lasting >30 seconds without antiarrhythmic drugs within 12 months. The key secondary end point was freedom from permanent pacemaker implantation. RESULTS: All 323 randomized patients were included in the intention-to-treat analysis (mean age, 56.5 years; 72.1% women; mean LA diameter, 51.9 mm). At 12 months, 78.7% of patients (129 of 164) in the biatrial group and 68.6% (109 of 159) in the LA group were free from atrial tachyarrhythmias (adjusted difference, 10.7% [1-sided lower 95% CI, 3%]; P =0.01). Freedom from permanent pacemaker implantation was noted in 97.0% (159 of 164) of the biatrial group and 98.1% (156 of 159) of the LA group, meeting the predefined noninferiority criterion with a margin of −5% (adjusted difference, –1.1% [1-sided lower 95% CI, –3.9%]; P noninferiority =0.01). CONCLUSIONS: Among patients with persistent or long-standing persistent AF undergoing rheumatic cardiac valve surgery, biatrial maze ablation was superior to LA maze ablation in reducing recurrent atrial tachyarrhythmias, while maintaining noninferiority with respect to permanent pacemaker implantation. These findings provide direct evidence to inform lesion-set selection for surgical ablation during cardiac surgery. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05021601.

CirculationVol. 154(20)
Central South University (CN), Shanghai Jiao Tong University (CN), Xiamen University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Sichuan University (CN), Kunming Medical University (CN), TEDA International Cardiovascular Hospital (CN), First Affiliated Hospital of Wenzhou Medical University (CN), Shanghai Chest Hospital (CN), Fuwai Yunnan Cardiovascular Hospital (CN), West China Hospital of Sichuan University (CN), Nanjing Drum Tower Hospital (CN), People's Hospital of Xinjiang Uygur Autonomous Region (CN), Wuhan Union Hospital (CN), Second Affiliated Hospital of Harbin Medical University (CN), Zhengzhou Central Hospital (CN), Guangdong Academy of Medical Sciences (CN), Jiangsu Province Hospital (CN), Second Xiangya Hospital of Central South University (CN), Guangdong Provincial People's Hospital (CN), Fu Wai Hospital (CN), First Affiliated Hospital Zhejiang University (CN), State Key Laboratory of Cardiovascular Disease (CN), Nanjing First Hospital (CN), Huazhong University of Science and Technology (CN), Zhejiang University (CN), Nanjing Medical University (CN), Nanjing University (CN)
Good health and well-being
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon